Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$4.46bn	97.97	n/a
MSBMesoblast	AU$2.93bn	n/a	n/a
PYCPYC Therapeutics	AU$1.85bn	n/a	n/a
CGSCogstate	AU$559.03m	26.98	1.21%
CU6Clarity Pharmaceuticals	AU$557.59m	n/a	n/a
RACRacura Oncology	AU$302.93m	n/a	n/a
TTXTetratherix	AU$291.70m	n/a	n/a
PEBPacific Edge	NZ$240.32m	n/a	n/a
ACWActinogen Medical	AU$152.40m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$143.29m	n/a	n/a
DXBDimerix	AU$123.08m	n/a	n/a
NYRNyrada	AU$113.66m	n/a	n/a
ILAIsland Pharmaceuticals	AU$85.82m	n/a	n/a
GD8GO-DX (Aust)	AU$84.74m	n/a	n/a
LTPLtr Pharma	AU$78.16m	n/a	n/a
ALAArovella Therapeutics	AU$61.05m	n/a	n/a
ATHAlterity Therapeutics	AU$57.64m	n/a	n/a
PTXPrescient Therapeutics	AU$55.73m	n/a	n/a
ADOAnteotech	AU$52.16m	n/a	n/a
ENPEntropy Neurodynamics	AU$48.77m	n/a	n/a